Centene director Wayne S. DeVeydt resigns; board size reduced to ten

Published 04/08/2025, 21:48
Centene director Wayne S. DeVeydt resigns; board size reduced to ten

Centene Corporation (NYSE:CNC), a $12.8 billion healthcare provider trading near its 52-week low of $25.11, announced the resignation of Director Wayne S. DeVeydt, effective immediately as of Friday. According to a company statement based on a Securities and Exchange Commission filing, Mr. DeVeydt notified Centene of his decision to resign from the board of directors on Friday.

The company stated that Mr. DeVeydt’s resignation was not the result of any dispute or disagreement with Centene or its board on matters relating to operations, policies, or practices.

Following Mr. DeVeydt’s departure, the board reduced its number of directors from eleven to ten. No additional details regarding the reasons for the resignation or plans for board succession were disclosed in the filing.

Centene Corporation is listed on the New York Stock Exchange under the ticker symbol CNC. This information is based on a press release statement included in the company’s recent SEC filing.

In other recent news, Centene Corporation reported its Q2 2025 earnings, revealing a significant miss with an adjusted loss per share of $0.16, contrary to the anticipated earnings per share of $0.23. Despite the earnings miss, Centene experienced a positive market reaction due to strong revenue performance and an optimistic outlook for future profitability. Meanwhile, Cantor Fitzgerald downgraded Centene’s stock rating from Overweight to Neutral, citing macroeconomic uncertainties in the Health Insurance Exchange and Medicaid markets. The investment firm expressed particular concern over Centene’s earnings exposure to the HIX segment. In another development, eHealth (NASDAQ:EHTH), Inc. announced the appointment of Derrick Duke as its new Chief Executive Officer, effective September 18, 2025. Duke will succeed Fran Soistman, who is retiring but will remain on the Board of Directors and serve as an executive advisor through the end of the year. These recent developments highlight significant changes and challenges within the health insurance sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.